Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Hectorol (Doxercalciferol) Capsules, 2.5 mcg, Bone Care International NDA 20-862 6/9/99 6/11/99 6/11/99 6/29/00 Hectorol Indication:For the reduction of elevated iPTH levels in the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis. Hectorol IV, Bone Care International NDA 21-027 Hectorol (doxercalciferol) Injection, Bone Care International Hectorol (Doxercalciferol) Capsules, Bone Care International | Hectorol (doxercalciferol) Capsules, Bone Care Intl., Labeling Revision | Hectorol (doxercalciferol) Injection, Bone Care Intl., Labeling Revision | Hectorol (doxercalciferol) Capsules, Bone Care Intl., Labeling Revision | Hectorol (doxercalciferol) Capsules, Genzyme Corp., Labeling Revision | Hectorol (doxercalciferol) Injection, Genzyme Corp., Labeling Revision | Hectorol (doxercalciferol) Capsules, Genzyme Corp., Control Supplement ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com